ETHZ Stock Analysis: Buy, Sell, or Hold?
ETHZ - ETHZilla Corporation Common Stock
$3.79
-0.05 (-1.30%)
▼
5d:
-24.2%
30d:
-25.83%
90d:
-80.7%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Get Alerted When ETHZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ETHZ this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ETHZ is down 24.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ETHZ is down 24.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ETHZ is currently trading at $3.79, which is considered oversold relative to its 30-day fair value range of $4.53 to $5.38.
Technical Outlook: Technically, ETHZ is showing sideways momentum. Immediate support is located at $3.50, while resistance sits at $5.41.
Market Sentiment: ETHZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ETHZ is showing sideways momentum. Immediate support is located at $3.50, while resistance sits at $5.41.
Market Sentiment: ETHZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$4.53 -
$5.38
Company Quality Score
48/100
(HOLD)
Options IV Signal
9th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
95.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 9th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- WARNING: Recommendation downgraded due to -24.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$4.53 -
$5.38
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.57
(15.0%)
Support & Resistance Levels
Support Level
$3.50
Resistance Level
$5.41
Current Trend
Sideways
Fundamental Context
Last updated: February 03, 2026 6:42 PM ET
Data refreshes hourly during market hours. Next update: 7:42 PM
Data refreshes hourly during market hours. Next update: 7:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ETHZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 60 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 62 BUY |
